General Info
The CF Syndicate in AMR is a cross-sector project that unites individuals with CF with top CF/AMR professionals from academia.
Location: Macclesfield
Country:
Industries:
Investment Regions: EU
Investment Stages: late-stage, pre-seed, seed, series-a
Website: https://cfamr.org.uk/
vc
EU
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: active
AI Reasoning: Search results show CF AMR Syndicate awarded funding to multiple projects in 2024 and 2025. Notable investments/awardees found: BioVersys (awarded non-dilutive funding, June 2024), Glox Therapeutics (awarded share of £3M programme, Jan 21, 2025), plus CDP first awardees announced Sep 24, 2024. The most recent known award is Glox Therapeutics on Jan 21, 2025, which is between 6 and 3 months prior to the reference date, placing the investor in the corresponding activity band.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of CF AMR Syndicate
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI